Ipilimumab? Ipilumumab is a common misspelling of ipilimumab.
By boosting the immune system and increasing the number of cancer-fighting cells, ipilimumab (Yervoy™) can help slow down the progression of melanoma skin cancer. Specifically, ipilimumab is approved for use when the cancer has spread to other areas in the body or cannot be treated surgically. It is administered intravenously (by IV) by a healthcare provider every three weeks for up to four doses.
Although many people may not have any problems with this medicine, some people who receive ipilimumab will experience side effects, such as fatigue, diarrhea, and a rash.
(For more information, click Ipilimumab. This full-length article offers a complete overview of this medication, including how it works, safety warnings and precautions, and general dosing guidelines. You can also click any of the links in the box to the right for specific information.)
HealthSavvy Sign In
|